These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1114 related items for PubMed ID: 30942874

  • 1. Identification and Validation of a Biomarker Signature in Patients With Resectable Pancreatic Cancer via Genome-Wide Screening for Functional Genetic Variants.
    Dimitrakopoulos C, Vrugt B, Flury R, Schraml P, Knippschild U, Wild P, Hoerstrup S, Henne-Bruns D, Wuerl P, Graf R, Breitenstein S, Bond G, Beerenwinkel N, Grochola LF.
    JAMA Surg; 2019 Jun 01; 154(6):e190484. PubMed ID: 30942874
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. CD44 SNPrs187115: A Novel Biomarker Signature that Predicts Survival in Resectable Pancreatic Ductal Adenocarcinoma.
    Stracquadanio G, Vrugt B, Flury R, Schraml P, Würl P, Müller TH, Knippschild U, Henne-Bruns D, Breitenstein S, Clavien PA, Graf R, Bond GL, Grochola LF.
    Clin Cancer Res; 2016 Dec 15; 22(24):6069-6077. PubMed ID: 27283965
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lack of association of CD44-rs353630 and CHI3L2-rs684559 with pancreatic ductal adenocarcinoma survival.
    Gentiluomo M, Corradi C, Vanella G, Johansen AZ, Strobel O, Szentesi A, Milanetto AC, Hegyi P, Kupcinskas J, Tavano F, Neoptolemos JP, Bozzato D, Hackert T, Pezzilli R, Johansen JS, Costello E, Mohelnikova-Duchonova B, van Eijck CHJ, Talar-Wojnarowska R, Hansen CP, Darvasi E, Chen IM, Cavestro GM, Soucek P, Piredda L, Vodicka P, Gazouli M, Arcidiacono PG, Canzian F, Campa D, Capurso G.
    Sci Rep; 2021 Apr 07; 11(1):7570. PubMed ID: 33828170
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biomarker panel predicts survival after resection in pancreatic ductal adenocarcinoma: A multi-institutional cohort study.
    Nahm CB, Turchini J, Jamieson N, Moon E, Sioson L, Itchins M, Arena J, Colvin E, Howell VM, Pavlakis N, Clarke S, Samra JS, Gill AJ, Mittal A.
    Eur J Surg Oncol; 2019 Feb 07; 45(2):218-224. PubMed ID: 30348604
    [Abstract] [Full Text] [Related]

  • 8. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
    Liu XG, Xu H, Chen M, Tan XY, Chen XF, Yang YG, Lin MZ, Liu GH, Liang XL, Qian YB, Yuan GJ, Chen MQ, Li WT, Miao HL, Li MY, Liao XW, Dai W, Chen NP.
    Cancer Med; 2020 Mar 07; 9(6):2062-2076. PubMed ID: 31991068
    [Abstract] [Full Text] [Related]

  • 9. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer.
    Hwang JH, Voortman J, Giovannetti E, Steinberg SM, Leon LG, Kim YT, Funel N, Park JK, Kim MA, Kang GH, Kim SW, Del Chiaro M, Peters GJ, Giaccone G.
    PLoS One; 2010 May 14; 5(5):e10630. PubMed ID: 20498843
    [Abstract] [Full Text] [Related]

  • 10. Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.
    Qian ZR, Rubinson DA, Nowak JA, Morales-Oyarvide V, Dunne RF, Kozak MM, Welch MW, Brais LK, Da Silva A, Li T, Li W, Masuda A, Yang J, Shi Y, Gu M, Masugi Y, Bui J, Zellers CL, Yuan C, Babic A, Khalaf N, Aguirre A, Ng K, Miksad RA, Bullock AJ, Chang DT, Tseng JF, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar M, Wollison B, Laing A, Hahn WC, Meyerson M, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Wolpin BM.
    JAMA Oncol; 2018 Mar 08; 4(3):e173420. PubMed ID: 29098284
    [Abstract] [Full Text] [Related]

  • 11. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
    Ruess DA, Makowiec F, Chikhladze S, Sick O, Riediger H, Hopt UT, Wittel UA.
    BMC Surg; 2015 Nov 28; 15():123. PubMed ID: 26615588
    [Abstract] [Full Text] [Related]

  • 12. Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma.
    Chen DT, Davis-Yadley AH, Huang PY, Husain K, Centeno BA, Permuth-Wey J, Pimiento JM, Malafa M.
    PLoS One; 2015 Nov 28; 10(8):e0133562. PubMed ID: 26247463
    [Abstract] [Full Text] [Related]

  • 13. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
    Wang X, Ren H, Zhao T, Ma W, Dong J, Zhang S, Xin W, Yang S, Jia L, Hao J.
    Oncotarget; 2016 Mar 22; 7(12):13717-29. PubMed ID: 26872370
    [Abstract] [Full Text] [Related]

  • 14. Association of Distinct Mutational Signatures With Correlates of Increased Immune Activity in Pancreatic Ductal Adenocarcinoma.
    Connor AA, Denroche RE, Jang GH, Timms L, Kalimuthu SN, Selander I, McPherson T, Wilson GW, Chan-Seng-Yue MA, Borozan I, Ferretti V, Grant RC, Lungu IM, Costello E, Greenhalf W, Palmer D, Ghaneh P, Neoptolemos JP, Buchler M, Petersen G, Thayer S, Hollingsworth MA, Sherker A, Durocher D, Dhani N, Hedley D, Serra S, Pollett A, Roehrl MHA, Bavi P, Bartlett JMS, Cleary S, Wilson JM, Alexandrov LB, Moore M, Wouters BG, McPherson JD, Notta F, Stein LD, Gallinger S.
    JAMA Oncol; 2017 Jun 01; 3(6):774-783. PubMed ID: 27768182
    [Abstract] [Full Text] [Related]

  • 15. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD, Fu ZQ, Lin Q, Zhou Y, Zhou QB, Li ZH, Tan LP, Chen RF, Liu YM.
    World J Gastroenterol; 2015 Aug 21; 21(31):9348-57. PubMed ID: 26309360
    [Abstract] [Full Text] [Related]

  • 16. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
    Wang WQ, Liu L, Xu HX, Wu CT, Xiang JF, Xu J, Liu C, Long J, Ni QX, Yu XJ.
    Br J Surg; 2016 Aug 21; 103(9):1189-99. PubMed ID: 27256393
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery.
    Sergeant G, van Eijsden R, Roskams T, Van Duppen V, Topal B.
    BMC Cancer; 2012 Nov 16; 12():527. PubMed ID: 23157946
    [Abstract] [Full Text] [Related]

  • 18. Update on the management of pancreatic cancer: surgery is not enough.
    Ansari D, Gustafsson A, Andersson R.
    World J Gastroenterol; 2015 Mar 21; 21(11):3157-65. PubMed ID: 25805920
    [Abstract] [Full Text] [Related]

  • 19. New challenges in perioperative management of pancreatic cancer.
    Puleo F, Maréchal R, Demetter P, Bali MA, Calomme A, Closset J, Bachet JB, Deviere J, Van Laethem JL.
    World J Gastroenterol; 2015 Feb 28; 21(8):2281-93. PubMed ID: 25741134
    [Abstract] [Full Text] [Related]

  • 20. Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes?
    Takeda Y, Saiura A, Takahashi Y, Inoue Y, Ishizawa T, Mise Y, Matsumura M, Ichida H, Matsuki R, Tanaka M, Ito H.
    J Gastrointest Surg; 2017 Aug 28; 21(8):1287-1295. PubMed ID: 28397027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.